The precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data Challenge is now live!
The purpose of this challenge is to advance techniques for the surveillance and detection of adverse events associated with FDA products. Participants are encouraged to use machine learning and artificial intelligence algorithms to automate the detection of anomalies in adverse event data. For more information and to get started, visit https://go.usa.gov/xdgMM.
Also, if you live in the DMV area and are interested in learning more about how FDA is modernizing its data strategy, attend the “Modernizing FDA’s Data Strategy” public meeting on March 27th.